Everything tagged "value" across research, earnings, and macro.
198 articles
Moderna is a transition story with real mRNA platform strength, but weak earnings and heavy COVID dependence keep it in Hold territory. The stock’s appeal hinges on late-stage pipeline catalysts and a cash runway that supports the pivot.
Apogee is a small-cap building-products name with strong cash generation, a healthy balance sheet, and a mix shift toward higher-margin businesses. Offsetting that are cyclical pressure in Architectural Glass and a still-muted earnings profile.
TD SYNNEX is pairing resilient distribution cash flow with a rapidly scaling Hyve infrastructure business. Strong revenue and EPS growth support a constructive Buy view, though valuation has tightened after a sharp run-up.
Trip.com Group combines fast international travel growth with strong profitability and a net cash balance. The stock looks attractive despite slower near-term guidance and regulatory risk.
Home Depot is still taking share despite a weak housing backdrop, with positive comps, strong online growth, and expanding Pro and specialty distribution channels. Valuation is not cheap, but the business mix is improving and management reaffirmed its 2026 outlook.
Uber has evolved into a profitable scaled marketplace, with 2025 revenue up 18% and free cash flow surging as Uber One and cross-platform usage deepen the moat.
Korn Ferry combines steady fee-revenue growth, strong free cash flow, and a net cash balance sheet with a valuation that still looks reasonable. The report argues the stock remains attractive below fair value despite cyclical labor-market risk.
AbbVie is showing that its post-Humira rebuild is real, with Skyrizi and Rinvoq driving strong growth and full-year guidance moving higher. Heavy debt and a negative equity position remain the main risks, but cash flow and earnings power still look compelling.
Infosys is a cash-rich IT services franchise with strong large-deal momentum, steady margins, and a measured FY27 growth outlook. The stock looks like a disciplined compounder rather than a breakout story.
Cognizant is combining low valuation, improving margins, and stronger bookings as it pushes deeper into AI-led services. The stock looks like a credible Buy for investors who want large-cap IT services exposure with cash generation and upside from mix improvement.
Space Exploration Technologies combines a leading launch franchise, a fast-growing Starlink network, and major operating leverage potential. The stock’s appeal is offset by a very rich valuation and ongoing net losses, making it a selective Hold.
CarMax is a scaled used-car franchise in the middle of a self-help turnaround, with improving retail trends, a $200M SG&A reset target, and meaningful finance and ancillary profit pools. The stock looks like a selective Buy, but earnings pressure, leverage, and used-car pricing risk keep the setup balanced.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator